AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS.
Bill status
passed
3 of 5 stages cleared
Introduction
Feb 2021
Committee Review
May 2021
Senate Passage
May 2021
House Passage
Governor
Introduced Feb 17, 2021
Last action May 27, 2021
Floor votes · Senate May 26, 2021
How they voted
23–11
Passed · 2 other
Total votes 36
May 26, 2021
D
Democratic24
91% Yea
R
Republican12
91% Nay
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
24
Key actions
4
Committee
9
May 26, 2021
Upper · Passed
SENATE PASSED
upper
May 18, 2021
Committee
NO NEW FILE BY COMM. ON Appropriations
upper
May 18, 2021
Introduced
FILED WITH LCO
upper
May 17, 2021
Upper · Passed
Joint Favorable
upper
May 12, 2021
Committee
REF. BY SEN. TO COMM. ON Appropriations
upper
May 4, 2021
Committee
NO NEW FILE BY COMM. ON Judiciary
upper
May 4, 2021
Introduced
FILED WITH LCO
upper
May 3, 2021
Upper · Passed
Joint Favorable
upper
Apr 28, 2021
Committee
REF. BY SEN. TO COMM. ON Judiciary
upper
Feb 26, 2021
Committee
REFERRED TO Office of Legislative Research AND Office of Fiscal Analysis 03/03/21
upper
Feb 17, 2021
Introduced
FILED WITH LCO
upper
Feb 16, 2021
Upper · Passed
Joint Favorable
upper
Jan 22, 2021
Committee
REF. TO JOINT COMM. ON General Law
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Martin Looney
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 262
Scope: CT
Hi! I can help you understand SB 262. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline